Animals learn to prefer flavors associated with the intake of dietary fats such as corn oil (CO) solutions. We previously reported that fat-conditioned flavor preferences in rats were relatively unaffected by systemic treatment with dopamine D1 and D2 antagonsits. The present study examined whether systemic opioid (naltrexone, NTX) or NMDA (MK-801) receptor antagonists altered the acquisition and/or expression of CO-CFP. The CFP was produced by training rats to drink one novel flavor (CS+, e.g., cherry) mixed in a 3.5% CO solution and another flavor (CSÀ, e.g., grape) in a 0.9% CO solution. In expression studies, food-restricted rats drank these solutions in one-bottle sessions (2 h) over 10 d. Subsequent two-bottle tests with the CS+ and CSÀ flavors mixed in 0.9% CO solutions occurred 0.5 h after systemic administration of vehicle (VEH), NTX (0.1-5 mg/kg) or MK-801 (50-200 lg/kg). Rats displayed a robust CS+ preference following VEH treatment (85-88%) which was significantly though moderately attenuated by NTX (69-70%). The lower doses of MK-801 slightly reduced the CS+ preference; the high dose blocked the CS+ preference (49%) but also markedly reduced overall CS intake. In separate acquisition studies, rats received VEH or NTX (0.1, 0.5, 1 mg/kg) or MK-801 (100 lg/kg) 0.5 h prior to 1-bottle training trials with CS+/3.5% CO and CSÀ/0.9% CO training solutions. Additional Limited VEH groups were trained with intakes limited to that of the NTX and MK-801 groups. Subsequent two-bottle CS+ vs. CSÀ tests were conducted without injections. Significant and persistent CS+ preferences were observed in VEH (77-84%) and Limited VEH (88%) groups. NTX treatment during training failed to block the acquisition of CO-CFP although the magnitude of the CS+ preference was reduced by 0.5 (70%) and 1.0 (72%) mg/kg doses relative to the Limited VEH treatment (88%). In contrast, MK-801 (100 lg/kg) treatment during training blocked the acquisition of the CO-CFP. These data suggest a critical role for NMDA, but not opioid receptor signaling in the acquisition of a fat conditioned flavor preferences, and at best limited involvement of NMDA and opioid receptors in the expression of a previously learned preference.
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Introduction
The overconsumption of sugars and fats appear to be triggered by both their inherent hedonic properties as well as their respective abilities to trigger learned preferences (Dela Cruz et al., 2012; Sclafani, 1999; Sclafani & Ackroff, 2012) . Preferences can be elicited on the basis of learned associations either between flavor cues and the orosensory aspects of sugars or fats (flavor-flavor conditioning), or between flavor cues and the nutrient's postingestive consequences (flavor-nutrient conditioning). The brain dopamine (DA) system has been identified as one neurochemical substrate of conditioned flavor preferences (CFPs) elicited by sugars (Azzara, Bodnar, Delamater, & Sclafani, 2001; Baker, Shah, Sclafani, & Bodnar, 2003; Hsiao & Smith, 1995; Yu, Silva, Sclafani, Delamater, & Bodnar, 2000a , 2000b . Flavor-flavor conditioning studies used rats that were either sham-fed sucrose (Yu et al., 2000a (Yu et al., , 2000b or real-fed fructose (Baker et al., 2003) , and identified a critical role for DA D1 and D2 receptor signaling in the acquisition and expression of a sweet taste-induced CFP. In contrast, flavor-nutrient conditioning studies involving intragastric (IG) sucrose infusions (Azzara, Bodnar, Delamater, & Sclafani, 2000) , identified a critical role for DA D1, but not D2 receptor signaling in the acquisition, and to a lesser degree, the expression of post-oral sugar-induced CFP. Brain sites involved in DA modulation of sugar-CFP include the nucleus accumbens (NAc: Bernal et al., 2008;  
